

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | drug catabolic process (GO:0042737) | 7.93661249 |
| 2 | exogenous drug catabolic process (GO:0042738) | 7.60959155 |
| 3 | glyoxylate metabolic process (GO:0046487) | 7.38070676 |
| 4 | oxidative demethylation (GO:0070989) | 6.04972059 |
| 5 | regulation of fibrinolysis (GO:0051917) | 5.97220372 |
| 6 | negative regulation of fibrinolysis (GO:0051918) | 5.83912214 |
| 7 | serine family amino acid catabolic process (GO:0009071) | 5.59040317 |
| 8 | epoxygenase P450 pathway (GO:0019373) | 5.57735632 |
| 9 | L-phenylalanine catabolic process (GO:0006559) | 5.54455007 |
| 10 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.54455007 |
| 11 | phenylpropanoid metabolic process (GO:0009698) | 5.34892520 |
| 12 | cellular glucuronidation (GO:0052695) | 5.34452173 |
| 13 | bile acid biosynthetic process (GO:0006699) | 5.31739773 |
| 14 | aromatic amino acid family catabolic process (GO:0009074) | 5.31090308 |
| 15 | uronic acid metabolic process (GO:0006063) | 5.19546509 |
| 16 | glucuronate metabolic process (GO:0019585) | 5.19546509 |
| 17 | tryptophan catabolic process (GO:0006569) | 5.10321686 |
| 18 | indole-containing compound catabolic process (GO:0042436) | 5.10321686 |
| 19 | indolalkylamine catabolic process (GO:0046218) | 5.10321686 |
| 20 | regulation of triglyceride catabolic process (GO:0010896) | 5.06631212 |
| 21 | drug metabolic process (GO:0017144) | 5.03132192 |
| 22 | omega-hydroxylase P450 pathway (GO:0097267) | 4.90166129 |
| 23 | alkaloid metabolic process (GO:0009820) | 4.82598585 |
| 24 | L-phenylalanine metabolic process (GO:0006558) | 4.75866472 |
| 25 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.75866472 |
| 26 | regulation of protein activation cascade (GO:2000257) | 4.71792176 |
| 27 | bile acid metabolic process (GO:0008206) | 4.70641676 |
| 28 | tryptophan metabolic process (GO:0006568) | 4.68980510 |
| 29 | glycine metabolic process (GO:0006544) | 4.65295830 |
| 30 | cellular ketone body metabolic process (GO:0046950) | 4.57501439 |
| 31 | bile acid and bile salt transport (GO:0015721) | 4.53981552 |
| 32 | negative regulation of sterol transport (GO:0032372) | 4.51291432 |
| 33 | negative regulation of cholesterol transport (GO:0032375) | 4.51291432 |
| 34 | fibrinolysis (GO:0042730) | 4.50031283 |
| 35 | S-adenosylmethionine metabolic process (GO:0046500) | 4.47950455 |
| 36 | blood coagulation, intrinsic pathway (GO:0007597) | 4.41158479 |
| 37 | arginine metabolic process (GO:0006525) | 4.39145590 |
| 38 | protein carboxylation (GO:0018214) | 4.36149381 |
| 39 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.36149381 |
| 40 | amino-acid betaine metabolic process (GO:0006577) | 4.32858230 |
| 41 | complement activation, alternative pathway (GO:0006957) | 4.28732844 |
| 42 | regulation of complement activation (GO:0030449) | 4.27368324 |
| 43 | acylglycerol homeostasis (GO:0055090) | 4.22209582 |
| 44 | triglyceride homeostasis (GO:0070328) | 4.22209582 |
| 45 | urea metabolic process (GO:0019627) | 4.18187459 |
| 46 | indolalkylamine metabolic process (GO:0006586) | 4.10278692 |
| 47 | ethanol oxidation (GO:0006069) | 4.04631040 |
| 48 | ketone body metabolic process (GO:1902224) | 4.03012897 |
| 49 | kynurenine metabolic process (GO:0070189) | 4.01520175 |
| 50 | serine family amino acid metabolic process (GO:0009069) | 3.91620487 |
| 51 | heme transport (GO:0015886) | 3.90030376 |
| 52 | aromatic amino acid family metabolic process (GO:0009072) | 3.86370551 |
| 53 | tyrosine metabolic process (GO:0006570) | 3.80229870 |
| 54 | nitrogen cycle metabolic process (GO:0071941) | 3.75541931 |
| 55 | L-methionine salvage (GO:0071267) | 3.73050613 |
| 56 | L-methionine biosynthetic process (GO:0071265) | 3.73050613 |
| 57 | amino acid salvage (GO:0043102) | 3.73050613 |
| 58 | high-density lipoprotein particle remodeling (GO:0034375) | 3.63254301 |
| 59 | flavonoid metabolic process (GO:0009812) | 3.62893384 |
| 60 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.61254042 |
| 61 | alpha-amino acid catabolic process (GO:1901606) | 3.59607349 |
| 62 | cellular biogenic amine catabolic process (GO:0042402) | 3.58882904 |
| 63 | amine catabolic process (GO:0009310) | 3.58882904 |
| 64 | behavioral response to nicotine (GO:0035095) | 3.51744039 |
| 65 | negative regulation of blood coagulation (GO:0030195) | 3.50198711 |
| 66 | negative regulation of hemostasis (GO:1900047) | 3.50198711 |
| 67 | intestinal cholesterol absorption (GO:0030299) | 3.48585894 |
| 68 | cysteine metabolic process (GO:0006534) | 3.47237090 |
| 69 | plasma lipoprotein particle remodeling (GO:0034369) | 3.40851785 |
| 70 | protein-lipid complex remodeling (GO:0034368) | 3.40851785 |
| 71 | macromolecular complex remodeling (GO:0034367) | 3.40851785 |
| 72 | steroid catabolic process (GO:0006706) | 3.39935027 |
| 73 | ethanol metabolic process (GO:0006067) | 3.36493767 |
| 74 | negative regulation of lipase activity (GO:0060192) | 3.36037409 |
| 75 | urea cycle (GO:0000050) | 3.34988588 |
| 76 | xenobiotic metabolic process (GO:0006805) | 3.32090308 |
| 77 | reverse cholesterol transport (GO:0043691) | 3.28442296 |
| 78 | phospholipid efflux (GO:0033700) | 3.25031330 |
| 79 | arginine catabolic process (GO:0006527) | 3.24724086 |
| 80 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.23460129 |
| 81 | drug transmembrane transport (GO:0006855) | 3.23114216 |
| 82 | regulation of lipoprotein particle clearance (GO:0010984) | 3.20723275 |
| 83 | negative regulation of coagulation (GO:0050819) | 3.19223420 |
| 84 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.18330268 |
| 85 | regulation of plasminogen activation (GO:0010755) | 3.17815440 |
| 86 | cellular amino acid catabolic process (GO:0009063) | 3.16711939 |
| 87 | vitamin biosynthetic process (GO:0009110) | 3.15180608 |
| 88 | aldehyde catabolic process (GO:0046185) | 3.13088604 |
| 89 | polyketide metabolic process (GO:0030638) | 3.12602753 |
| 90 | doxorubicin metabolic process (GO:0044598) | 3.12602753 |
| 91 | daunorubicin metabolic process (GO:0044597) | 3.12602753 |
| 92 | indole-containing compound metabolic process (GO:0042430) | 3.12573244 |
| 93 | negative regulation of wound healing (GO:0061045) | 3.10941359 |
| 94 | protein activation cascade (GO:0072376) | 3.07010363 |
| 95 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.06901088 |
| 96 | cholesterol efflux (GO:0033344) | 3.06482791 |
| 97 | negative regulation of protein activation cascade (GO:2000258) | 3.01540337 |
| 98 | benzene-containing compound metabolic process (GO:0042537) | 3.00736825 |
| 99 | hormone catabolic process (GO:0042447) | 2.99126176 |
| 100 | dopamine transport (GO:0015872) | 2.94461606 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.30803668 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.75452713 |
| 3 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.31670843 |
| 4 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.82431617 |
| 5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.70970418 |
| 6 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.61445296 |
| 7 | VDR_22108803_ChIP-Seq_LS180_Human | 2.54684797 |
| 8 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.49392032 |
| 9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.38962553 |
| 10 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.38649326 |
| 11 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.37146914 |
| 12 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.35616673 |
| 13 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.22060806 |
| 14 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.16379421 |
| 15 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.07438112 |
| 16 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.99613911 |
| 17 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.96348165 |
| 18 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.88455271 |
| 19 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.86919902 |
| 20 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.86118890 |
| 21 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.84369539 |
| 22 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.77729352 |
| 23 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.76068263 |
| 24 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.70369886 |
| 25 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.59589678 |
| 26 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.58579051 |
| 27 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.57992632 |
| 28 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.52971163 |
| 29 | P300_19829295_ChIP-Seq_ESCs_Human | 1.50692352 |
| 30 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.50243678 |
| 31 | FUS_26573619_Chip-Seq_HEK293_Human | 1.48705908 |
| 32 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.45731477 |
| 33 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.42663531 |
| 34 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.42437572 |
| 35 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.42153821 |
| 36 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.37535797 |
| 37 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.37535797 |
| 38 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.37458280 |
| 39 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.37122989 |
| 40 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.35953587 |
| 41 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.35953587 |
| 42 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.33873448 |
| 43 | AR_20517297_ChIP-Seq_VCAP_Human | 1.33798908 |
| 44 | STAT3_23295773_ChIP-Seq_U87_Human | 1.33746903 |
| 45 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.33038736 |
| 46 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.32641734 |
| 47 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.32641734 |
| 48 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.28567601 |
| 49 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.28134891 |
| 50 | * GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.27400334 |
| 51 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.26820707 |
| 52 | NCOR_22424771_ChIP-Seq_293T_Human | 1.26561518 |
| 53 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.26154500 |
| 54 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.25974492 |
| 55 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.21375218 |
| 56 | AR_25329375_ChIP-Seq_VCAP_Human | 1.21245967 |
| 57 | EWS_26573619_Chip-Seq_HEK293_Human | 1.19953030 |
| 58 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.19863519 |
| 59 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.19616836 |
| 60 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.19216745 |
| 61 | TCF4_23295773_ChIP-Seq_U87_Human | 1.18499700 |
| 62 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.18456088 |
| 63 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.17395749 |
| 64 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.16818097 |
| 65 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.14280950 |
| 66 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.13839980 |
| 67 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.10400593 |
| 68 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.09325203 |
| 69 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.09216915 |
| 70 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.09160381 |
| 71 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.08754915 |
| 72 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.07983967 |
| 73 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.07200492 |
| 74 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.05960705 |
| 75 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.05405128 |
| 76 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04651657 |
| 77 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.04651657 |
| 78 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.03763042 |
| 79 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.03340098 |
| 80 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.01387743 |
| 81 | ERA_21632823_ChIP-Seq_H3396_Human | 1.00749194 |
| 82 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.00556718 |
| 83 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.00171330 |
| 84 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.99208566 |
| 85 | * FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.99161851 |
| 86 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.98395290 |
| 87 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.98300117 |
| 88 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.97530678 |
| 89 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.97437573 |
| 90 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.97125211 |
| 91 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.96843908 |
| 92 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.96384650 |
| 93 | TP53_16413492_ChIP-PET_HCT116_Human | 0.96325565 |
| 94 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.96180554 |
| 95 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.95713758 |
| 96 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.94852219 |
| 97 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.94790876 |
| 98 | * TAF2_19829295_ChIP-Seq_ESCs_Human | 0.94252521 |
| 99 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.93361103 |
| 100 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.93343208 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.40316953 |
| 2 | MP0005085_abnormal_gallbladder_physiolo | 5.34385316 |
| 3 | MP0005360_urolithiasis | 5.28484811 |
| 4 | MP0003195_calcinosis | 5.21844717 |
| 5 | MP0005365_abnormal_bile_salt | 4.96032228 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.56033011 |
| 7 | MP0002138_abnormal_hepatobiliary_system | 4.53236973 |
| 8 | MP0002876_abnormal_thyroid_physiology | 3.29356841 |
| 9 | MP0003252_abnormal_bile_duct | 3.26936369 |
| 10 | MP0003868_abnormal_feces_composition | 2.83338538 |
| 11 | MP0009697_abnormal_copulation | 2.79132158 |
| 12 | MP0001666_abnormal_nutrient_absorption | 2.50296938 |
| 13 | MP0010329_abnormal_lipoprotein_level | 2.41411521 |
| 14 | MP0005332_abnormal_amino_acid | 2.18535462 |
| 15 | MP0001764_abnormal_homeostasis | 1.94448289 |
| 16 | MP0003806_abnormal_nucleotide_metabolis | 1.86306690 |
| 17 | MP0008872_abnormal_physiological_respon | 1.63059873 |
| 18 | MP0005551_abnormal_eye_electrophysiolog | 1.55202413 |
| 19 | MP0003011_delayed_dark_adaptation | 1.54582357 |
| 20 | MP0004019_abnormal_vitamin_homeostasis | 1.44678240 |
| 21 | MP0002118_abnormal_lipid_homeostasis | 1.43173918 |
| 22 | MP0009840_abnormal_foam_cell | 1.42837958 |
| 23 | MP0005645_abnormal_hypothalamus_physiol | 1.26215756 |
| 24 | MP0001986_abnormal_taste_sensitivity | 1.26152369 |
| 25 | MP0006292_abnormal_olfactory_placode | 1.25403983 |
| 26 | MP0005084_abnormal_gallbladder_morpholo | 1.23768709 |
| 27 | MP0000569_abnormal_digit_pigmentation | 1.22986607 |
| 28 | MP0000609_abnormal_liver_physiology | 1.18257044 |
| 29 | MP0003646_muscle_fatigue | 1.15978910 |
| 30 | MP0004142_abnormal_muscle_tone | 1.12947782 |
| 31 | MP0002638_abnormal_pupillary_reflex | 1.11751530 |
| 32 | MP0005646_abnormal_pituitary_gland | 1.08265487 |
| 33 | MP0001968_abnormal_touch/_nociception | 1.04116611 |
| 34 | MP0009745_abnormal_behavioral_response | 1.00790792 |
| 35 | MP0005187_abnormal_penis_morphology | 0.99626363 |
| 36 | MP0002102_abnormal_ear_morphology | 0.97710085 |
| 37 | MP0010386_abnormal_urinary_bladder | 0.96067842 |
| 38 | MP0003718_maternal_effect | 0.94428007 |
| 39 | MP0009643_abnormal_urine_homeostasis | 0.91497832 |
| 40 | MP0003638_abnormal_response/metabolism_ | 0.91222164 |
| 41 | MP0002837_dystrophic_cardiac_calcinosis | 0.90896794 |
| 42 | MP0008877_abnormal_DNA_methylation | 0.89582206 |
| 43 | MP0004043_abnormal_pH_regulation | 0.88723255 |
| 44 | MP0000372_irregular_coat_pigmentation | 0.88594118 |
| 45 | MP0009764_decreased_sensitivity_to | 0.87655580 |
| 46 | MP0002928_abnormal_bile_duct | 0.87178612 |
| 47 | MP0005319_abnormal_enzyme/_coenzyme | 0.86098206 |
| 48 | MP0001501_abnormal_sleep_pattern | 0.85853601 |
| 49 | MP0005636_abnormal_mineral_homeostasis | 0.85387934 |
| 50 | MP0009046_muscle_twitch | 0.84597425 |
| 51 | MP0005083_abnormal_biliary_tract | 0.83693668 |
| 52 | MP0005408_hypopigmentation | 0.82820976 |
| 53 | MP0005253_abnormal_eye_physiology | 0.77577414 |
| 54 | MP0002272_abnormal_nervous_system | 0.76972749 |
| 55 | MP0003186_abnormal_redox_activity | 0.76315320 |
| 56 | MP0004133_heterotaxia | 0.75858016 |
| 57 | MP0002653_abnormal_ependyma_morphology | 0.73742071 |
| 58 | MP0009642_abnormal_blood_homeostasis | 0.73693295 |
| 59 | MP0005410_abnormal_fertilization | 0.73487609 |
| 60 | MP0003136_yellow_coat_color | 0.72280179 |
| 61 | MP0002064_seizures | 0.72222945 |
| 62 | MP0003880_abnormal_central_pattern | 0.71362387 |
| 63 | MP0002736_abnormal_nociception_after | 0.70932829 |
| 64 | MP0002938_white_spotting | 0.70506751 |
| 65 | MP0005376_homeostasis/metabolism_phenot | 0.70051352 |
| 66 | MP0006072_abnormal_retinal_apoptosis | 0.69960012 |
| 67 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.69093433 |
| 68 | MP0005395_other_phenotype | 0.68505628 |
| 69 | MP0005535_abnormal_body_temperature | 0.68423094 |
| 70 | MP0001485_abnormal_pinna_reflex | 0.66532818 |
| 71 | MP0005448_abnormal_energy_balance | 0.66071218 |
| 72 | MP0003879_abnormal_hair_cell | 0.65348825 |
| 73 | MP0006276_abnormal_autonomic_nervous | 0.65268170 |
| 74 | MP0005379_endocrine/exocrine_gland_phen | 0.64476024 |
| 75 | MP0004130_abnormal_muscle_cell | 0.63183070 |
| 76 | MP0001324_abnormal_eye_pigmentation | 0.61473594 |
| 77 | MP0002078_abnormal_glucose_homeostasis | 0.60510416 |
| 78 | MP0005266_abnormal_metabolism | 0.60171924 |
| 79 | MP0003959_abnormal_lean_body | 0.59928597 |
| 80 | MP0006036_abnormal_mitochondrial_physio | 0.59798066 |
| 81 | MP0005195_abnormal_posterior_eye | 0.59041507 |
| 82 | MP0002735_abnormal_chemical_nociception | 0.57689130 |
| 83 | MP0002282_abnormal_trachea_morphology | 0.57175827 |
| 84 | MP0004147_increased_porphyrin_level | 0.56768545 |
| 85 | MP0000598_abnormal_liver_morphology | 0.55889310 |
| 86 | MP0004145_abnormal_muscle_electrophysio | 0.55887557 |
| 87 | MP0000230_abnormal_systemic_arterial | 0.55845673 |
| 88 | MP0003953_abnormal_hormone_level | 0.55678982 |
| 89 | MP0001661_extended_life_span | 0.54609158 |
| 90 | MP0000427_abnormal_hair_cycle | 0.54396839 |
| 91 | MP0005171_absent_coat_pigmentation | 0.54011436 |
| 92 | MP0001502_abnormal_circadian_rhythm | 0.51649412 |
| 93 | MP0005167_abnormal_blood-brain_barrier | 0.51075066 |
| 94 | MP0002733_abnormal_thermal_nociception | 0.50981991 |
| 95 | MP0002572_abnormal_emotion/affect_behav | 0.50746975 |
| 96 | MP0005386_behavior/neurological_phenoty | 0.50619584 |
| 97 | MP0004924_abnormal_behavior | 0.50619584 |
| 98 | MP0004885_abnormal_endolymph | 0.50394923 |
| 99 | MP0002090_abnormal_vision | 0.49688745 |
| 100 | MP0001905_abnormal_dopamine_level | 0.49338365 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 6.16776524 |
| 2 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.04311489 |
| 3 | Prolonged partial thromboplastin time (HP:0003645) | 6.00644661 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 5.24453877 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.58943012 |
| 6 | Complement deficiency (HP:0004431) | 4.04205390 |
| 7 | Hyperglycinemia (HP:0002154) | 3.92803590 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 3.88409032 |
| 9 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.66972437 |
| 10 | Hyperglycinuria (HP:0003108) | 3.61252122 |
| 11 | Joint hemorrhage (HP:0005261) | 3.49158143 |
| 12 | Congenital stationary night blindness (HP:0007642) | 3.47781901 |
| 13 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.46060146 |
| 14 | Abnormality of glycine metabolism (HP:0010895) | 3.46060146 |
| 15 | Conjugated hyperbilirubinemia (HP:0002908) | 3.36938528 |
| 16 | Xanthomatosis (HP:0000991) | 3.33338223 |
| 17 | Abnormality of serum amino acid levels (HP:0003112) | 3.26163065 |
| 18 | Abnormal biliary tract physiology (HP:0012439) | 3.23485629 |
| 19 | Bile duct proliferation (HP:0001408) | 3.23485629 |
| 20 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.20261051 |
| 21 | Intrahepatic cholestasis (HP:0001406) | 3.19058330 |
| 22 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.16523372 |
| 23 | Abnormality of alanine metabolism (HP:0010916) | 3.16523372 |
| 24 | Hyperalaninemia (HP:0003348) | 3.16523372 |
| 25 | Fair hair (HP:0002286) | 3.15107274 |
| 26 | Generalized aminoaciduria (HP:0002909) | 3.11479312 |
| 27 | Pancreatic cysts (HP:0001737) | 3.06345293 |
| 28 | Delayed CNS myelination (HP:0002188) | 2.99381384 |
| 29 | Hyperventilation (HP:0002883) | 2.91980850 |
| 30 | Ketosis (HP:0001946) | 2.81263705 |
| 31 | Abnormality of midbrain morphology (HP:0002418) | 2.80685939 |
| 32 | Molar tooth sign on MRI (HP:0002419) | 2.80685939 |
| 33 | Glycosuria (HP:0003076) | 2.79173426 |
| 34 | Abnormality of urine glucose concentration (HP:0011016) | 2.79173426 |
| 35 | Abnormality of complement system (HP:0005339) | 2.78490879 |
| 36 | Type II lissencephaly (HP:0007260) | 2.77125526 |
| 37 | Systemic lupus erythematosus (HP:0002725) | 2.76248359 |
| 38 | Hyperammonemia (HP:0001987) | 2.76094056 |
| 39 | Hypolipoproteinemia (HP:0010981) | 2.68058927 |
| 40 | Pancreatic fibrosis (HP:0100732) | 2.63121257 |
| 41 | True hermaphroditism (HP:0010459) | 2.60952817 |
| 42 | Abnormality of the renal cortex (HP:0011035) | 2.59661448 |
| 43 | Epidermoid cyst (HP:0200040) | 2.53285190 |
| 44 | Abolished electroretinogram (ERG) (HP:0000550) | 2.53094568 |
| 45 | Chronic hepatic failure (HP:0100626) | 2.50813412 |
| 46 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.49356648 |
| 47 | Metabolic acidosis (HP:0001942) | 2.47825477 |
| 48 | Spontaneous abortion (HP:0005268) | 2.47261864 |
| 49 | Glomerulonephritis (HP:0000099) | 2.45867282 |
| 50 | Nephronophthisis (HP:0000090) | 2.39899803 |
| 51 | Hypothermia (HP:0002045) | 2.35933658 |
| 52 | Renal cortical cysts (HP:0000803) | 2.35598224 |
| 53 | Attenuation of retinal blood vessels (HP:0007843) | 2.34295059 |
| 54 | Abnormality of proline metabolism (HP:0010907) | 2.32077752 |
| 55 | Hydroxyprolinuria (HP:0003080) | 2.32077752 |
| 56 | Arthropathy (HP:0003040) | 2.31319478 |
| 57 | Generalized hypopigmentation of hair (HP:0011358) | 2.30586518 |
| 58 | Pendular nystagmus (HP:0012043) | 2.29865592 |
| 59 | Lethargy (HP:0001254) | 2.28323877 |
| 60 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.28267852 |
| 61 | Alkalosis (HP:0001948) | 2.25066587 |
| 62 | Reduced antithrombin III activity (HP:0001976) | 2.21713668 |
| 63 | Ketoacidosis (HP:0001993) | 2.20468056 |
| 64 | Decreased central vision (HP:0007663) | 2.19347437 |
| 65 | Hyperphosphaturia (HP:0003109) | 2.12596613 |
| 66 | Osteomalacia (HP:0002749) | 2.12354542 |
| 67 | Inability to walk (HP:0002540) | 2.10650761 |
| 68 | Chorioretinal atrophy (HP:0000533) | 2.09088712 |
| 69 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.07897795 |
| 70 | Abnormality of vitamin metabolism (HP:0100508) | 2.06463309 |
| 71 | Fat malabsorption (HP:0002630) | 2.05984489 |
| 72 | Abnormality of the renal medulla (HP:0100957) | 2.02846122 |
| 73 | Abnormality of the common coagulation pathway (HP:0010990) | 2.00626576 |
| 74 | Increased corneal curvature (HP:0100692) | 1.95273743 |
| 75 | Keratoconus (HP:0000563) | 1.95273743 |
| 76 | Abnormality of methionine metabolism (HP:0010901) | 1.94396563 |
| 77 | Tubular atrophy (HP:0000092) | 1.94114247 |
| 78 | Nephritis (HP:0000123) | 1.93882509 |
| 79 | Proximal tubulopathy (HP:0000114) | 1.89296585 |
| 80 | Acute encephalopathy (HP:0006846) | 1.88997750 |
| 81 | Cerebral edema (HP:0002181) | 1.88762771 |
| 82 | Rickets (HP:0002748) | 1.88175883 |
| 83 | Cystic liver disease (HP:0006706) | 1.80259089 |
| 84 | Abnormality of nucleobase metabolism (HP:0010932) | 1.79177777 |
| 85 | Large for gestational age (HP:0001520) | 1.78747283 |
| 86 | Cerebellar dysplasia (HP:0007033) | 1.77027533 |
| 87 | Steatorrhea (HP:0002570) | 1.75922472 |
| 88 | Male pseudohermaphroditism (HP:0000037) | 1.75164389 |
| 89 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.74247706 |
| 90 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.73545589 |
| 91 | Abnormal drinking behavior (HP:0030082) | 1.73134781 |
| 92 | Polydipsia (HP:0001959) | 1.73134781 |
| 93 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.72041083 |
| 94 | 3-Methylglutaconic aciduria (HP:0003535) | 1.69471360 |
| 95 | Azoospermia (HP:0000027) | 1.69363861 |
| 96 | Progressive inability to walk (HP:0002505) | 1.69277849 |
| 97 | Pigmentary retinal degeneration (HP:0001146) | 1.68832421 |
| 98 | Gaze-evoked nystagmus (HP:0000640) | 1.68452569 |
| 99 | Medial flaring of the eyebrow (HP:0010747) | 1.67252848 |
| 100 | Irritability (HP:0000737) | 1.65811914 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 5.11383493 |
| 2 | ADRBK2 | 3.77519659 |
| 3 | BMPR1B | 3.30746416 |
| 4 | ZAK | 3.04991590 |
| 5 | ACVR1B | 3.00120657 |
| 6 | PINK1 | 2.89924046 |
| 7 | MAP4K2 | 2.89053163 |
| 8 | TLK1 | 2.80570681 |
| 9 | TAOK3 | 2.72918769 |
| 10 | GRK1 | 2.54129872 |
| 11 | INSRR | 2.38878528 |
| 12 | WNK3 | 2.37367058 |
| 13 | WNK4 | 2.33629548 |
| 14 | CASK | 1.93155559 |
| 15 | MAP3K4 | 1.68834706 |
| 16 | MAPK13 | 1.66861882 |
| 17 | CAMKK2 | 1.66014251 |
| 18 | DAPK2 | 1.65079798 |
| 19 | MAPKAPK3 | 1.56082309 |
| 20 | NUAK1 | 1.55297052 |
| 21 | BCKDK | 1.45412949 |
| 22 | PRKCG | 1.43360680 |
| 23 | EPHA3 | 1.34672123 |
| 24 | PIK3CG | 1.31518753 |
| 25 | PIK3CA | 1.29183949 |
| 26 | OXSR1 | 1.28814563 |
| 27 | TNIK | 1.27193009 |
| 28 | STK39 | 1.24663774 |
| 29 | ADRBK1 | 1.24472063 |
| 30 | NTRK3 | 1.20531883 |
| 31 | PRKCE | 1.08274475 |
| 32 | DYRK2 | 1.06154089 |
| 33 | PAK3 | 1.01830134 |
| 34 | MAP2K7 | 1.01572843 |
| 35 | TGFBR1 | 1.00252896 |
| 36 | VRK1 | 0.92817827 |
| 37 | MAP2K6 | 0.91139317 |
| 38 | TXK | 0.91105813 |
| 39 | TIE1 | 0.87957650 |
| 40 | MARK1 | 0.85482416 |
| 41 | STK38L | 0.82635225 |
| 42 | RPS6KA5 | 0.80119279 |
| 43 | PRKCQ | 0.78524851 |
| 44 | PHKG1 | 0.76976347 |
| 45 | PHKG2 | 0.76976347 |
| 46 | BRSK2 | 0.75942828 |
| 47 | IKBKB | 0.75760792 |
| 48 | MUSK | 0.75427762 |
| 49 | IRAK1 | 0.73784826 |
| 50 | PRKAA2 | 0.73650323 |
| 51 | PRKACG | 0.73076204 |
| 52 | OBSCN | 0.70537576 |
| 53 | MAP2K4 | 0.70503685 |
| 54 | PRKACA | 0.70118265 |
| 55 | PNCK | 0.68675238 |
| 56 | PRKAA1 | 0.67730571 |
| 57 | PTK2B | 0.67609892 |
| 58 | MAPK15 | 0.64344974 |
| 59 | EPHA4 | 0.62938620 |
| 60 | PRKCZ | 0.61907420 |
| 61 | ERBB2 | 0.59410781 |
| 62 | MAPKAPK5 | 0.59133045 |
| 63 | TEC | 0.54967321 |
| 64 | CDK8 | 0.54878764 |
| 65 | PRKCI | 0.54396952 |
| 66 | TNK2 | 0.53532613 |
| 67 | CHUK | 0.53412031 |
| 68 | CSNK1D | 0.53250595 |
| 69 | PRKCA | 0.51175843 |
| 70 | PRKG1 | 0.50840639 |
| 71 | CSNK1G1 | 0.50811464 |
| 72 | MAP2K2 | 0.50374713 |
| 73 | CSNK1G2 | 0.49933366 |
| 74 | PKN1 | 0.49600844 |
| 75 | MAP2K1 | 0.49318171 |
| 76 | CSNK1G3 | 0.48384464 |
| 77 | IGF1R | 0.47400007 |
| 78 | CAMK2A | 0.47329056 |
| 79 | CSNK1A1 | 0.47126854 |
| 80 | PLK2 | 0.45563160 |
| 81 | MKNK2 | 0.45270322 |
| 82 | MAPK11 | 0.44940794 |
| 83 | TRPM7 | 0.44085560 |
| 84 | KIT | 0.42570517 |
| 85 | CSNK1A1L | 0.38817109 |
| 86 | BCR | 0.38020381 |
| 87 | CAMK1D | 0.37920057 |
| 88 | NLK | 0.37573073 |
| 89 | NTRK2 | 0.34860691 |
| 90 | CAMKK1 | 0.34153295 |
| 91 | CAMK4 | 0.33389013 |
| 92 | PRKCB | 0.31858029 |
| 93 | ERBB3 | 0.31002537 |
| 94 | GRK7 | 0.30977856 |
| 95 | SIK2 | 0.27891054 |
| 96 | CAMK1 | 0.27666350 |
| 97 | PRKCH | 0.27525146 |
| 98 | ITK | 0.26512558 |
| 99 | PRKACB | 0.25658248 |
| 100 | RPS6KA3 | 0.24976404 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.06216676 |
| 2 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.75981648 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.40684162 |
| 4 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.12565738 |
| 5 | Retinol metabolism_Homo sapiens_hsa00830 | 3.04749915 |
| 6 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.81719946 |
| 7 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.76303388 |
| 8 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.70844439 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.70640586 |
| 10 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.64311197 |
| 11 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.59067381 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.55618566 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.51268471 |
| 14 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.38980046 |
| 15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.22802862 |
| 16 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.15751984 |
| 17 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.98856034 |
| 18 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.91394611 |
| 19 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.87537821 |
| 20 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.82424395 |
| 21 | Peroxisome_Homo sapiens_hsa04146 | 1.80245966 |
| 22 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.75838533 |
| 23 | Bile secretion_Homo sapiens_hsa04976 | 1.70978288 |
| 24 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.70839262 |
| 25 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.68974650 |
| 26 | Histidine metabolism_Homo sapiens_hsa00340 | 1.68372419 |
| 27 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.64608916 |
| 28 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.63324489 |
| 29 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.59616172 |
| 30 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.55757502 |
| 31 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.45748117 |
| 32 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.42834811 |
| 33 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.42116608 |
| 34 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.37004717 |
| 35 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.26769328 |
| 36 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.26076777 |
| 37 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.23666182 |
| 38 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.22791796 |
| 39 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.20613564 |
| 40 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.15312237 |
| 41 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.14110378 |
| 42 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.12784710 |
| 43 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.04668508 |
| 44 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.02779573 |
| 45 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.01896447 |
| 46 | Sulfur relay system_Homo sapiens_hsa04122 | 1.00934298 |
| 47 | ABC transporters_Homo sapiens_hsa02010 | 1.00330602 |
| 48 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.98529452 |
| 49 | Phototransduction_Homo sapiens_hsa04744 | 0.95915483 |
| 50 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.95829077 |
| 51 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.89383366 |
| 52 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.76075257 |
| 53 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.75660262 |
| 54 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.72762621 |
| 55 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.71009789 |
| 56 | Metabolic pathways_Homo sapiens_hsa01100 | 0.60792983 |
| 57 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.56826578 |
| 58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.56379086 |
| 59 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.54334338 |
| 60 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.53985582 |
| 61 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.53771075 |
| 62 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.51159195 |
| 63 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.47662034 |
| 64 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.47308645 |
| 65 | Lysine degradation_Homo sapiens_hsa00310 | 0.42406407 |
| 66 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.38813792 |
| 67 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.38739736 |
| 68 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.34379718 |
| 69 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.33948977 |
| 70 | Mineral absorption_Homo sapiens_hsa04978 | 0.33517337 |
| 71 | Nicotine addiction_Homo sapiens_hsa05033 | 0.33124465 |
| 72 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.32533469 |
| 73 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.29997047 |
| 74 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.29375478 |
| 75 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.29004787 |
| 76 | Carbon metabolism_Homo sapiens_hsa01200 | 0.27837548 |
| 77 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.27697983 |
| 78 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.24174517 |
| 79 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.23490219 |
| 80 | Protein export_Homo sapiens_hsa03060 | 0.22690645 |
| 81 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.22038563 |
| 82 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.20962326 |
| 83 | Olfactory transduction_Homo sapiens_hsa04740 | 0.20815232 |
| 84 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.19910652 |
| 85 | Parkinsons disease_Homo sapiens_hsa05012 | 0.15536764 |
| 86 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.14598421 |
| 87 | Taste transduction_Homo sapiens_hsa04742 | 0.13731818 |
| 88 | RNA polymerase_Homo sapiens_hsa03020 | 0.13184940 |
| 89 | Insulin secretion_Homo sapiens_hsa04911 | 0.12023486 |
| 90 | Morphine addiction_Homo sapiens_hsa05032 | 0.09534418 |
| 91 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.08707776 |
| 92 | GABAergic synapse_Homo sapiens_hsa04727 | 0.06307132 |
| 93 | Homologous recombination_Homo sapiens_hsa03440 | 0.05111461 |
| 94 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.04546737 |
| 95 | Basal transcription factors_Homo sapiens_hsa03022 | 0.01466984 |
| 96 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.00640890 |
| 97 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.00243694 |
| 98 | Glutamatergic synapse_Homo sapiens_hsa04724 | -0.0054252 |
| 99 | Insulin resistance_Homo sapiens_hsa04931 | -0.0032914 |
| 100 | Asthma_Homo sapiens_hsa05310 | -0.0003204 |

